"10.1371_journal.pone.0043840","none","2012-09-24T00:00:00Z","Corey T Watson; Giulio Disanto; Geir Kjetil Sandve; Felix Breden; Gavin Giovannoni; Sreeram V Ramagopalan","Department of Biological Sciences, Simon Fraser University, Burnaby, British Columbia, Canada; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Department of Clinical Neurology, University of Oxford, The West Wing, John Radcliffe Hospital, Oxford, United Kingdom; Department of Informatics, University of Oslo, Blindern, Oslo, Norway; Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, United Kingdom; Medical Research Council Functional Genomics Unit, Department of Physiology, Anatomy & Genetics, University of Oxford, Oxford, United Kingdom","Conceived and designed the experiments: SVR CTW GD. Performed the experiments: CTW GD GKS FB. Analyzed the data: CTW GD GKS FB. Contributed reagents/materials/analysis tools: GKS. Wrote the paper: CTW SVR. Critical revision of the manuscript for important intellectual content: GD GKS FB GG SVR. Study supervision: SVR.","The authors have the following interests. Dr. Giovannoni serves on scientific advisory boards for Merck Serono and Biogen Idec and Vertex Pharmaceuticals; has served on the editorial board of Multiple Sclerosis; has received speaker honoraria from Bayer Schering Pharma, Merck Serono, Biogen Idec, Pfizer Inc, Teva Pharmaceutical Industries Ltd.â€sanofiaventis, Vertex Pharmaceuticals, Genzyme Corporation, Ironwood, and Novartis; has served as a consultant for Bayer Schering Pharma, Biogen Idec, GlaxoSmithKline, Merck Serono, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd.â€sanofiaventis, UCB, Vertex Pharmaceuticals, GW Pharma, Novartis, and FivePrime; serves on the speakers bureau for Merck Serono; and has received research support from Bayer Schering Pharma, Biogen Idec, Merck Serono, Novartis, UCB, Merz Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd.â€sanofiaventis, GW Pharma, and Ironwood. There are no patents, products in development, or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","09","Corey T Watson","CTW",6,TRUE,3,4,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
